OVERVIEW OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION AT HOSPITAL BENEFICÊNCIA PORTUGUESA RIBEIRÃO PRETO – SP
DOI:
https://doi.org/10.56238/levv17n57-039Keywords:
Interventional Cardiology, Myocardial Revascularization, StentAbstract
Cardiovascular disease is the leading cause of death in Brazil and worldwide. It presents in three main forms: coronary artery disease, stroke, and peripheral arterial disease. Among these, the most prevalent and most fatal is coronary artery disease, which causes myocardial ischemia and, if not treated in a timely manner, leads to necrosis. To prevent myocardial death, it is necessary for the patient to undergo revascularization, which may be performed through percutaneous coronary intervention or coronary artery bypass graft surgery. The choice between these approaches depends on the degree of arterial involvement and the number of affected vessels. Thus, a high percentage of obstruction and involvement of multiple arteries constitute a strong indication for surgical treatment. Therefore, considering the high clinical relevance of this disease, a study is being conducted to compare the sociodemographic data of patients undergoing procedures with the use of drug-eluting stents and non–drug-eluting stents.
Downloads
References
1. BHAT, Fayaz Ahmad et al. Transradial versus transfemoral approach for coronary angiography and angioplasty: a prospective, randomized comparison. BMC Cardiovascular Disorders, Londres, v. 17, n. 1, p. 23, 2017. DOI: 10.1186/s12872-016-0457-.
2. BØNAA, Kaare H. et al. Drug-eluting or bare-metal stents for coronary artery disease. New England Journal of Medicine, Boston, v. 375, n. 13, p. 1242–1252, 2016.
3. BRASIL. Ministério da Saúde. Portaria nº 3.693, de 17 de dezembro de 2021. Altera atributos de procedimentos na Tabela de Procedimentos, Medicamentos, Órteses, Próteses e Materiais Especiais do SUS. Diário Oficial da União, Brasília, DF, 17 dez. 2021.
4. BUNDHUN, Pravesh Kumar; YANAMALA, Chaitanya M.; HUANG, Fang. Percutaneous coronary intervention, coronary artery bypass surgery and the SYNTAX score: a systematic review and meta-analysis. Scientific Reports, Londres, v. 7, p. 43801, 2017. DOI: 10.1038/srep43801.
5. FERES, Fausto et al. Diretriz da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista sobre Intervenção Coronária Percutânea. Arquivos Brasileiros de Cardiologia, Rio de Janeiro, v. 109, n. 1, p. 1–81, 2017.
6. FERREIRA, Elbio et al. Análise de custo-efetividade dos stents farmacológicos e não farmacológicos na doença coronariana. Arquivos Brasileiros de Cardiologia, Rio de Janeiro, v. 94, n. 3, p. 306–312, 2010.
7. GUO, Liang; LV, Hui-Chao; HUANG, Rui-Chang. Percutaneous coronary intervention in elderly patients with coronary chronic total occlusions: current evidence and future perspectives. Clinical Interventions in Aging, v. 15, p. 771–781, 2020. DOI: 10.2147/CIA.S252318.
8. KANDAN, Sanjay R.; JOHNSON, Thomas W. Manejo das complicações da intervenção coronária percutânea. Heart, Londres, v. 105, n. 1, p. 75–86, 2019. DOI: 10.1136/heartjnl-2017-311155.
9. KING, Spencer B. III. How does angioplasty work? Cardiovascular Revascularization Medicine, v. 24, p. 89–90, 2021. DOI: 10.1016/j.carrev.2020.12.008.
10. KUHN, Otávio T.; BUENO, Juliana F. B.; LORO, Marlise M. et al. Perfil de pacientes submetidos a cateterismo cardíaco e angioplastia em um hospital geral. Revista Contexto & Saúde, Ijuí, v. 15, n. 29, p. 4–14, 2015.
11. LIMA, Marília S. M. de et al. Clinical-epidemiological aspects of patients submitted to percutaneous coronary intervention in a university hospital. Revista Brasileira de Enfermagem, Brasília, v. 71, n. 6, p. 2883–2890, 2018.
12. MENEGUZ-MORENO, Rodrigo A. et al. Long-term follow-up of patients after percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffold. Arquivos Brasileiros de Cardiologia, Rio de Janeiro, v. 108, n. 2, p. 109–115, 2017.
13. MILAN, Vanessa B. et al. Diferenças entre os sexos nos desfechos de pacientes com infarto do miocárdio com supradesnivelamento do segmento ST submetidos à intervenção coronária percutânea primária. Arquivos Brasileiros de Cardiologia, Rio de Janeiro, v. 120, n. 6, p. e20220673, 2023.
14. NEUMANN, Franz-Josef et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, Oxford, v. 40, n. 2, p. 87–165, 2019. DOI: 10.1093/eurheartj/ehy394.
15. NICOLAU, José Carlos et al. Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021. Arquivos Brasileiros de Cardiologia, Rio de Janeiro, v. 117, n. 1, p. 181–264, 2021.
16. ORGANIZAÇÃO MUNDIAL DA SAÚDE. Doenças cardiovasculares (DCV). Genebra: OMS, 2021.
